Huitian Lin

Huitian Lin

Auto-generated profile, based on publicly available information

Huitian Lin

Zhejiang University of Technology

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2024 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XWXinyi Wu
Xinyi Wu
HLHuitian Lin
Huitian Lin
Renren BaiRenren Bai
Renren Bai
HDHongliang Duan
Hongliang Duan

23 May 2025 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HLHuitian Lin
Huitian Lin
CZCheng Zhu
Cheng Zhu
TSTianfeng Shang
Tianfeng Shang
NZNing Zhu
Ning Zhu
KLKang Lin
Kang Lin
HDHongliang Duan
Hongliang Duan

20 August 2026 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MLMinhui Lan
Minhui Lan
CZChengyun Zhang
Chengyun Zhang
WWWentong Wang
Wentong Wang
HHHaomeng Hu
Haomeng Hu
HLHuitian Lin
Huitian Lin
HDHongliang Duan
Hongliang Duan

17 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
HLHuitian Lin
Huitian Lin
CZCheng Zhu
Cheng Zhu
TSTianfeng Shang
Tianfeng Shang
NZNing Zhu
Ning Zhu
KLKang Lin
Kang Lin
HDHongliang Duan
Hongliang Duan
The structural diversity and good biocompatibility of cyclic peptides has led to their emergence as potential therapeutic agents. Traditional cyclic peptide design relies on natural template modification and combinatorial chemical library screening, but suffers from bottlenecks such as limited molecular diversity, high cost, and time-consuming.AI technologies have improved design efficiency by predicting target binding patterns and generating scaffold structures, but they still require extensive laboratory screening. In this study, we propose HighPlay, which integrates reinforcement learning (Monte Carlo Tree Search) with the HighFold structure prediction model to design cyclic peptide sequences for protein targets, dynamically exploring the sequence space without the need of predefined target information. The model was applied to the design of cyclic peptide sequences for three different targets, which were screened and verified by molecular dynamics simulation, and showed good binding affinity. Specifically, the cyclic peptide sequences designed for TEAD4 target showed micromolar-level affinity in further experimental validation.